The rbp9 gene of Drosophila melanogaster has been molecularly characterized and shown to be expressed solely in the CNS, where it encodes proteins with three RNA recognition motifs (RRMs). Sequencing of genomic and cDNA clones of rbp9 revealed a complex gene with three alternative promoters as well as alternative patterns of splicing. The deduced amino acid sequence of the RBP9 proteins is highly similar to those of three other nervous system-specific genes, human HuC and HUD and Drosophila elav, which also encode proteins with three RRMs. Developmental
Northern analysis revealed that rbp9 is expressed from the late third instar larva through adult stages. The RBP9 protein was detected specifically in nuclei of the nervous system after morphogenesis of the adult CNS in the mid-pupal stage. Thus, the RBP9 protein does not appear until substantially later than rbp9 transcripts are detected. The adult nervous system nuclear-limited expression pattern, the presence of RRMs, and the high similarity to a group of nervous systemspecific proteins in flies and humans suggest that rbp9 belongs to a nervous system-specific RRM protein gene subfamily that may participate in the processing of RNAs involved in the development of the CNS. [Key words: RNA recognition motif (RRM), CNS, nuclear protein, neural RRM protein] Substantial postembryonic neurogenesis is required for the synthesis of the adult CNS in Drosophila. In particular, during the transition from larva to adult, the number of neurons in the CNS increases drastically. Large numbers of new neurons are produced from a small number of larval neuronal stem cells. These neurons are growth arrested during the early stages of development only to differentiate into adult neurons at the onset of metamorphosis (Truman and Bate, 1988) . As these new neurons mature, their physiological as well as morphological nature changes. These physiological and morphological changes accompany specific changes in gene expression. Therefore, it is apparent that a tightly orchestrated regulation ofgene expression is required for proper CNS development.
Gene expression in the developing embryonic CNS has been shown to be regulated by a number of homeotic genes, which encode putative transcription factors (Doe and Scott, 1988) . However, the discovery of nervous system-specific genes with RNA recognition motifs (RRMs)-a region of 80-90 amino acids, across which there are 21 conserved residues and which have been shown to be the RNA binding site in several proteins with this motif(for reviews, see Dreyfuss et al., 1988; Bandziulis et al., 1989; Mattaj, 1989; Kenan et al., 1991) -such as elav of Drosophila (Robinow et al., 1988) , nrp-I of Xenopus (Richter et al., 1990) , and two human nervous system-specific proteins, HUD (Szabo et al., 199 1) and HuC (H. M. Furneaux, personal communication) , raises the possibility that the neurogenesis may also be regulated at the level of RNA metabolism.
The involvement of differential RNA processing mechanisms in the regulation of development has been shown in many cases. For example, the sex determination genes of Drosophila (reviewed in Baker, 1989) , the rat tropomyosin gene (Breitbart and Nadal-Ginard, 1987) , several viral genes (Berk and Sharp, 1978; Ziff, 1982) and the calcitonin/calcitonin gene-related peptide gene (Rosenfeld et al., 1984) make different proteins in different tissues by regulating alternative splicing. In particular, the tissue-specific production of neuropeptides in the nervous system (Kitamura et al., 1983; Rosenfeld et al., 1984) strongly indicates that nervous system development may also be controlled at the RNA processing level.
Our previous studies on the RRM-type RNA binding protein gene family in Drosophila (Rim and Baker, in press) identified several RRM sequences that have a high similarity to tissuespecific RRM-containing proteins. Among them, RRM2, RRM9, and RRM 10 have a high similarity to a group ofnervous system-specific proteins. Therefore, we characterized the gene encoding one of them, RRM9, with the hope of finding links between nervous system development and RNA processing.
Here we report a detailed molecular characterization of the structure and expression pattern of the gene rbp9 that encodes RRM9. Our results show that the expression of rbp9 is highly regulated both temporally and spatially. We also show that the RBP9 protein is expressed only in the nuclei of the nervous system after the mid-pupal stage and that it has a high sequence similarity to human and Drosophila nervous system-specific proteins that also contain RRMs. These results suggest that rbp9 may be involved in the development of the nervous system perhaps by acting as a regulator of nervous system-specific RNA processing decisions.
Materials and Methods
Screening of cDNA and cosmid libraries. Recombinant phages (2 x 105)
were screened from each of the following libraries: a Xgt 10 adult fly and a pupa cDNA library (provided by L. Kauvar, USCF), a Xnvx third instar larva cDNA library (provided by S. Elledge, Baylor College of Medicine), and hzau head cDNA librarv (nrovided bv Y. Jan. USCF). We also screened < x 10' colonies from 'a Drosophiia co&&j library (provided by J. W. Tamkun, NIH), and 2 x lo5 recombinant phages from a Charon Drosophila genomic library (Maniatis et al., 1978) . All the procedures used for the isolation of positive clones followed conventional protocols (Sambrook et al., 1989) . Sequencing of the cDNA and genomic DNA. The cDNA fragments from the nine positive cDNA clones were subcloned into pBluescript (pSK+) vectors. Unidirectional deletions were introduced into the cloned fragments using Exonuclease III and nuclease SI. Single-stranded templates were prepared by standard methods, and sequenced by the method of Sanger et al. (1977) . The rbp9 gene was localized within a 12 kilobase (kb) genomic fragment by Southern hybridizations.
A contiguous set of genomic fragments encompassing the entire region homologous to the cDNAs was subcloned into pSK+ vectors and sequenced as described above for the cDNAs.
Computer programs used for sequence analysis were from the University of Wisconsin GCG package (Devereux et al., 1984) . The GenBank (release 62.0) and EMBL (release 22.0) nucleotide sequence databases were scanned with the program TFASTA for the homologous proteins. The promoter &-element analysis used the FPS-dependent sequence retrieval programs (Bucher and Bryan, 1984) in combination with the program FASTA to screen the Eukaryotic Promoter Database (EPD) for common promoter elements.
Primer extension and anchor PCR. Seven oligonucleotides were used to map and clone the 5' end of each transcript. The two oligonucleotides were designed from exon 1 (primer 1 la: 5'-TTGGCGCTGA-TATTGCCTTC-3') and exon 5 (primer 55: 5'-TGAGTA-ATGTGGTATGTCAG-3').
The '"P-kinased primers were annealed separately with 20 pg of polyA+ RNA and then extended with reverse transcriptase using the method described by Sambrook et al. (1989) . The extended cDNAs were separated on the 5% acrylamide, 7 M urea gel and autoradiographed.
cDNA was also prepared from 25 fig of polyA+ RNA using an oligo dT ,&," primer. The 3' end of cDNA was dG tailed with dGTP and terminal transferase, and then amplified using primer 1 la or 55 with an anchor PCR primer mix (9 parts oligonucleotide anchor C: 5'-GCATGCGCGCGGCCGCGGAGGCCCCCCCCCCCCCC-3', 1 part oligonucleotide anchor: 5'-GCATGCGCGCGGCCGCGGAGGCC-3') by PCR for 10 cycles of I' at 95°C 1' at 5o"C, and 1' at 74°C. The PCR products were precipitated with a half volume of 20% PEG6000. 2.5 M NaCl to remove the primers. They were then reamplified using primer 11 b (5'-CCTGGGGATCTCACCCACAAAAT-3').
mimer or primer with the oligonucleotide anchor for another 20 cycles under the same conditions. The amplified fragments were subcloned into pSK+ vector and sequenced.
To make sections for immunostainings, y w embryos, larvae, pupae, and adults were embedded in OCT compound and frozen with liquid CO,. Frozen flies were cut 8 pm thick in an SLEE cryostat, and serial sections were mounted on subbed slides. The sections were fixed in PBS containing 4% paraformaldehyde for 30 min. After blocking with 5% goat serum in 50 mM Tris-HCl (pH 8), 150 mM NaCl, 0.5% NP-40, the sections were incubated with affinity-purified anti-RBP9 antibodies at a dilution of 1: 100. Fluorescein-conjugated goat anti-rabbit IgG antibody (Cappel) at a 1: 100 dilution and 1 &ml bis-benzimide were used, respectively, to make the RBP9 protein-antibody complex and DNA visible. Slides were mounted in 80% glycerol, 2% n-propyl gallate. The sections were viewed under epifluorescence optics using a Zeiss Axiophot microscope and photographed with Kodak Ektachrome P8001 PI600 film.
Polymerase chain reaction for exon usage. The primer 1 (5'-Results ATTCTTCGAATTCATCG-3') of exon 1, the primer 2 (5'-GAAAACCCTTAGTGTGT-3') of exon 3. and the mimer 3 (5'-GTTGCAGGAACGCGTTC-3') of exon 4 are homologous to the'~5' ends of the transcripts from Pl, P2, and P3, respectively. The primer ex9(-) (5 and the primer ex9(+) (5'-gcccttggagagacCCGCA-3') share the same 14 nucleotides (shown as lower case) from exon 10 at their 5' ends, but have five nucleotides (shown as upper case) at the 3' ends that are homologous to exon 8 and exon 9, respectively. One hundred nanograms of rbp9 cDNA was used as a template for each combination of primers. PCRs were carried out for 25 cycles at 1' at 95°C 1' at 57°C 1' at 72°C and the products were resolved on the 1% agarose gel electrophoresis.
Northern analysis. For developmental Northern analysis, 5 pg of polyA+ RNA from each developmental stage was separated on a 1% agarose-formaldehyde gel and transferred to Nytran. The filters were hybridized with '*P-labeled probes prepared from the type P 1, type P2, and type P3 cDNAs by random hexamer labeling. Hybridizations were done using the conditions described by Sambrook et al. (1989) .
Production of polyclonal antibodies to lacZRBP9 fusion protein. A 2.0 kb EcoRI fragment from type Pl cDNA was subcloned into the EcoRI site of plasmid aWR590-0 (Guo et al.. 1984) to make oZrbn9. which contained a truncated Escierichia cob P-gaiactosidase cod& region fused in frame to the carboxy-terminal 176 amino acids of rbp9. One liter of dYT broth containing 100 &ml carbenicillin was inoculated with JM 10 1 -pZrbp9, and the culture was induced with IPTG (isopropyl fl-D-thiogalactopyranoside) (final concentration of 0.5 mM)
at the late log phase. After 2 hr at 37°C the cells were harvested and frozen at -80°C until use. The cells were resuspended in 50 mM TrisHCl (pH 7.5) 250 mM NaCl and lysed with lysozyme and 1% Triton X-100. After sonication, the lysate was centrifuged at 10,000 x g for 30 min through a 20% sucrose cushion to pellet inclusion bodies. The pellet was resuspended in 8 M urea solubilization buffer, and the salts were removed by dialysis. After dialysis, the soluble fraction was separated on a 4% stacking, 8% polyacrylamide SDS gel. The fusion protein band was eluted from the gel, dialyzed against distilled water, and then lyophilized.
About 200 fig of fusion protein was added to one vial of MPL+TDM+CWS adjuvant (RIB1 Immunochem) and injected into two New Zealand White rabbits according to the manufacturers' instructions.
Ajinity purification of anti-RBP9 antibodies. The same 2.0 kb EcoRI fragment used to make pZRBP9 was subcloned into plasmid pATH3 to make pTrbp9, which has the C-terminal 176 amino acids fused in frame after an E. coli trpE. Five milligrams of trpE fusion protein was prepared from a liter of an M9 minimal media culture of JMlO l-pTRBP9 induced by indoleacetic acid using the protein purification procedure described above for the lac-RBP9 fusion protein. The purified trpE-RBP9 fusion protein was coupled to Affigel-10 (Bio-Rad) at a concentration of 2 mg/ml resin according to the manufacturer's instructions. After coupling, blocking, and washing, the resins were mixed overnight with a 5-lo-fold diluted serum from immunized rabbits. The next morning, after plenty of washing, the bound antibodies were eluted with 2 or 3 ml of 0.1 M glycine, pH 2.8, and neutralized immediately with 30 ml of 1 M Tris-HCl. nH 9.0. and then stored with 0.02% Na-azide and 1% BSA.
_
Western blots and tissue section staining. Crude nuclear extracts from embryos, larvae, pupae, and adult flies were prepared as described in Kuroda et al. (1991) . Electrophoresis of nuclear extracts, transfer of protein to nitrocellulose, and immunostaining of the blots were performed as described in Harlow and Lane (1988) .
Cloning ofthe rbp9 gene. In a previous report (Rim and Baker, in press), we reported the identification of 12 new RRM sequences. Among the 12 RRM sequences, RRM9 and RRM 10 showed significant similarities to the RRMs of the Drosophila nervous system-specific gene elav. Since we were particularly interested in RRMs that might be part of proteins having regulatory roles at the level of RNA processing during development, we chose RRM9 to characterize further. Later, the sequence analysis of the gene (rbp9) encoding RRM9 revealed that rbp9 has three RRMs and that both RRM9 and RRMlO were derived from different RRMs in the same gene; RRM9 was amplified from the third RRM whereas RRM 10 came from the first RRM.
In order to clone the rbp9 gene, and determine its structure, nine independent cDNA clones containing sequences homologous to the RRM9 were isolated from four different cDNA libraries. Comparison of the restriction maps of these cDNAs suggested that there are several types of rbp9 mRNAs (data not shown).
To determine the structures of the rbp9 gene and its transcripts, the nucleotide sequences for each of the 9 cDNA clones . Each cDNA used one of the three different sequences at the 5' noncoding regions (denoted Pl, P2, and P3), and these cDNAs with the alternatively used exon 9 (see below) are designated types Pl t-9, P2+9, and P3+9. In order to map the 5' ends of type PI +9, P2+9, and P3+9 mRNAs, anchor PCR (Loh et al., 1989) and primer extension assays were performed using specific primers made from the 5' end of corresponding cDNA. This revealed that type P 1 + 9, P2 + 9, and P3 + 9 mRNAs start from genomic positions $148, +2288, and +4235, respectively. Thus, each transcript is transcribed from one of the three different promoters, Pl, P2, and P3, respectively, rather than being generated by alternative processing of a precursor RNA. The structures of the rbp9 transcripts representing each cDNA types are depicted in Figure 1 . The type Pl + 9 mRNA has eight exons and encodes an open reading frame (ORF) of 444 amino acids (RBP9-1) with the AUG located at +66 18 and the stop codon at +8871 of the genomic sequence. This mRNA is made from Pl and uses exons 1 and 2 at the 5' noncoding region. The 3' untranslated region extends about 1.5 kb beyond the stop codon, and no ORF with the Drosophila codon-preference pattern is found within this region. The 3' end of the mRNA is polyadenylated at + 10241 between the first AAUAAA (+ 102 17) and T-stretch (+ 10252-10260). Three more AAUAAA exist within 600 base pair (bp) downstream of the first polyA signal, but there is no obvious GT-stretch after them. In addition, only the first polyadenylation site was used in the cDNAs we sequenced.
The type P2+9 mRNA is made from the P2 promoter and has exons 3, 5, and 6 in the 5' noncoding region. This mRNA differs from the type P1+9 mRNA only in the 5' noncoding sequence. Except for this 5' end, this mRNA shares the same coding sequence, 3' noncoding sequence, and polyadenylation site with the type Pi +9 mRNA. The type P3+9 mRNA is made from the P3 promoter and has exons 4, 5, and 6 in the 5' noncoding region. Furthermore, this mRNA shares the same coding, 3' noncoding sequences, and polyadenylation site with the previous two mRNA types.
In addition to the variations at the 5' noncoding region resulting from the alternative usage of promoters, exon 9 was alternatively used in the type P2 cDNAs. The mRNA with exon 9 is designated type P2+9, whereas mRNA without exon 9 is designated type P2-9. Type P2-9 mRNA differs from type P2+9 mRNA only by the absence of exon 9. Since exon 9 is 15 nucleotides, P2 -9 type mRNAs encodes a 439 amino acid ORF (RBP9-2) which is the same as the 444 amino acid ORF (RBP9-1) of type P2+9 mRNAs except for the 5 amino acid deletion. Though both RBP9-1 and RBP9-2 encoding cDNAs were identified from type P2 cDNAs, only RBP9-l-encoding cDNAs were found from the type Pl and P3 cDNAs we isolated. This observation prompted us to ask whether there were any links between the promoter used and the alternative splicing of the mini exon 9.
Alternative usage ofexon 9. The pattern of alternative usage of the 15 nucleotide exon 9 was confirmed by PCR amplification. Two DNA fragments were amplified from adult fly cDNA with primers made from the neighboring exons 8 and 10 (Fig.  3A) . The nucleotide sequences of the two PCR-amplified fragments showed that the small fragment was amplified from the RNA without exon 9 and the large fragment was amplified from the RNA with exon 9 (data not shown). In order to find out whether exon 9 usage was specifically coupled to the usage of particular promoters, we examined the presence of exon 9 in and ex9( +) share the same 14 nucleotides from exon 10 at their each type of transcript (P 1, P2, and P3) using 5' primers specific 5' ends, but have 5 nucleotides at their 3' ends, which are hoto each transcript type. The 5' primer for each of the Pl, P2, mologous to exon 8 or exon 9, respectively]. Since the splice and P3 mRNAs was made from sequences within exon 1, exon junction lies very close to the 3' end of the primers, no PCR 3, and exon 4, respectively, whereas the two 3' primers were amplification was observed when P2+9 cDNA was used with made to distinguish the transcript with exon 9 from the one ex9(-) primer, nor when P2-9 cDNA was used with primer without the exon by making each of the 3' primers compleex9( +). Since exon 9 is only 15 bp, the PCR-amplified products mentary to the splice junction sequences between exon 8 and from the same promoter-type mRNAs were not resolved during 10, and between exon 9 and 10, respectively [primer ex9 (-) agarose gel electrophoresis. However, the 5' primers were made Since' the expected size of the fragment amplified using each of the 5' primers and ex9(-) primer is different only 15 nucleotides from that amplified using the same 5' primer and ex9(+) primer, the two PCR products from the same type RNA appear to have the same size in the agarose gel electrophoresis; their size from each reaction is as follows: 1.40 kb from type Pl RNA, 1.15 kb from type P2 RNA, and 1.35 kb from type P3 RNA.
in such a way that PCR-amplified fragments from each of the 5' primers had a unique size: 1.40 kb from Pl RNA, 1.15 kb from P2 RNA, and 1.35 kb from P3 RNA. Fragments of the expected sizes, both with and without exon 9, were amplified from transcripts of all three promoter types (Fig. 3B) . Thus, the alternative usage of exon 9 is independent of which promoter is used. Therefore, a total of six types of mRNAs and two types of proteins are made from the rbp9 gene. However, the size difference between the six rbp9 transcripts is so small, despite the utilization of three different promoters and alternative exon use, that they are not expected to be resolvable on Northern analysis. Similarly, the two types of the RBP9 proteins would have very similar size, thereby making the two proteins indistinguishable on the basis of size in Western analysis. Promoter sequence analysis. Drosophila promoter sequences from -200 to + 10 relative to transcriptional start sites were A) P2 Antp Adh-adult DDC GgAgCTCtGCCGCTOggGCCGcGCACTGc (-83-45) GtGcCGCcGCCGCCCccCACTgCGCTGCa (-9-T-68) CtGcTGCtGCCGCCCtcGACGtCGACTGc t-82--54) GaAgTTCaGCGGCTCcgCACTgCCATTCa t-98--69)
The Journal of Neuroscience, March 1993, 13(3) 1051 retrieved from EPD (Bucher, 1988) using an FPS-dependent sequence retrieval program (Bucher and Bryan, 1984) . In order to identify sequence similarities between the promoters of rbp9 and those in the database, the 1398 nucleotides between exon 2 and 3 (Pt2), the 1878 nucleotides between exon 3 and 4 (Pt3), and the 147 nucleotides (which was the available sequence) in front of the exon I (Ptl) were compared with the Drosophila promoter sequences retrieved from the EPD. The database search revealed three sequences that were similar to sequences in the promoters of known genes; two had distinctive motifs, the functions of which have been identified, and one had a significant nucleotide sequence repeat of unknown function (Fig. 4) . Their positions relative to a transcription initiation site are shown at the right side of each sequence in Figure 4 , and the comparisons of these sequences to the known promoter elements are also shown. First, a repeat of "GCCGCYG" at -83 to -55 of Pt2 is similar to the Adf-1 binding sequence. England et al. (1990) showed that "GCCGCYG" is a consensus Adf-1 binding sequence and activates transcription from the promoters of Antp (Schneuwly et al., 1986) , Adh (Heberlein et al., 1985) and Ddc (Scholnick et al., 1986) when Adf-1 binds to them. The Adf-1 binding is sequence specific and enhances the level of transcription in conjunction with other transcription factors.
The second motif was a 35 nucleotide sequence from Pt3, which shows 72% identity to a sequence in the promoter of the ecdysone-inducible gene Eip28/29 (Cherbas et al., 1991) . In addition to the sequence similarity, these 35 nucleotides also have the sequence "TGAATC" with a partially inverted symmetry around the first "T," which has been found to be a consensus sequence of ecdysone-responsive elements of Eip28/29 (Cherbas et al., 1991) . Because the rbp9 transcript is first detectable in the late larval period when metamorphosis is beginning under the influence of high levels of ecdysone, the presence of a potential ecdysone responsive element in the promoter of rbp9 may indicate the involvement of ecdysone in the regulation of rbp9 transcription.
The third motif found in the rbp9 promoters was a long "CT" repeat that was found three times in the P2 and P3 promoters. A similar sequence was also found in the promoter region of the as-c t4 transcription unit (Villares and Cabrera, 1987) that is involved in neurogenesis in the embryo. Even though there are no data as to the role of these repeats, the degree of conservation of the repeats may suggest that t4 and rbp9 have some common aspects to their regulation, perhaps due to functioning of both of these genes in the nervous system. Developmental profile of the rbp9 RNA and protein expression. The developmental Northern analysis of rbp9 showed that a 3.5 kb RNA species was expressed from the third larval instar through the adult stages (Fig. 5~) .
To determine the temporal profile of the expression of each promoter, we used an RNase protection assay that allows direct comparison of the amount of RNAs produced from each of the three promoters throughout development. A uniformly labeled riboprobe harboring small pieces of rbp9 genomic DNA near the transcription initiation site of each promoter was used to detect the use of each promoter by generating RNase-protected fragments of distinct sizes (Fig. 6) . The RNase protection assay showed that the type Pl and P2 transcripts are expressed from the third instar larval period through adulthood. However, the amounts of the Pl and P2 transcripts in the larval and early pupal stages were greater than in the adult. The type P3 transcript, on the other hand, was most highly expressed in the adult stage (Fig. 6) . Therefore, most of the adult transcripts detected in the developmental Northern analysis are the product of the P3 promoter, while usage of the Pl and P2 promoters is mainly responsible for the transcripts of the larval and early pupal stages.
Polyclonal anti-RBP9 antibodies were raised against the carboxy-terminal 176 amino acids of the RBP9 protein using a lacZ-RBP9 fusion protein as an immunogen and affinity purified using a trpE-RBP9 fusion protein column. Western analysis of the fusion proteins using the affinity-purified anti-RBP9 antibodies showed that the anti-RBP9 antibodies reacted strongly to the trpE-RBP9 and lacZ-RBP9 fusion proteins with little or no reactivity to 1acZ and trpE proteins, respectively. No specific reactivity was detected from the preimmune sera (data not shown). Nuclear extracts were prepared from each developt three promoters. The restriction enzyme sites used to subclone the genomic fragments are indicated, and linker sequences used to clone the genomic sequences into a vector are shown as thin lines. The exon sequences are indicated as boxes, and the intron sequences are shown as thick lines. The expected sizes of the protected fragments are shown at the bottom ofthe probe as shaded boxes. As a reference for the amount of RNA used in each lane, rp49 probe was incubated together with the rbp9 probe, and the intensity of the signal from rp49 is also shown. mental stage and identical amounts of protein were used for a developmental Western analysis. This analysis showed that, in the pupal and adult stages, the anti-RBP9 antibodies recognized only a single band of 50 kDa that was approximately the size of the RBP9 protein predicted from the cDNA sequence. However, no protein was detected by the anti-RBP9 antibodies in the nuclear extracts of embryos and larvae (Fig. 5b) .
A comparison of the developmental Northern and Western analyses of rbp9 shows that RBP9 protein is only detected at stages substantially later than when transcripts first appear. Several mechanisms may account for this regulation, and we are currently in the process of testing various possibilities. Localization of RBP9 protein using indirect immunojluorescence. To examine the expression pattern of RBP9 protein, cryosections of Drosophila were reacted with anti-RBP9 antibodies and visualized by indirect immunofluorescence. As controls for the tissue staining, preimmune sera with or without a secondary antibody, or a secondary antibody alone was used to stain tissue sections. No positive staining was observed in these controls (data not shown). When sections of adult flies were stained with the anti-RBP9 antibodies, the RBP9 protein is detected only in the nerve cell bodies of the CNS (Fig. 7b,d ). The RBP9 protein is specifically localized on the nuclei of the nerve cells. In particular, the nuclei of the brain and thoracic ganglion are the most heavily labeled, whereas low levels of the RBP9 protein are detected in the nuclei of the lamina cell body layer and antennae.
In order to examine the pattern of RBP9 protein expression throughout development, flies from larval, pupal, and adult stages were serially sectioned (8 pm) and the distribution of RBP9 protein was visualized by indirect immunofluorescence. These sections were also stained with bis-benzimide to visualize nuclei. The nuclear staining patterns documented the substantial morphological change that the CNS undergoes during the midpupal period (Fig. 7a ,c,e; reviewed in Kankel et al., 1980) . After metamorphosis, the CNS has two distinct masses, the brain and thoracic ganglion, and RBP9 protein is detected in virtually all of nuclei of the brain and thoracic ganglion. Since we detected a low level of RBP9 proteins in early pupae by the Western analysis, we carefully examined the serial sections of earlier stages for the possibility that only a small number ofcells express rbp9. However, RBP9 protein is not detected in CNS at early stages (embryos, larvae, and l-d-old pupae; Fig. 7b,d ). This suggests that neither the larval nervous system, nor the precursor cells of the adult CNS express RBP9 protein. rbp9 has a high similarity to HUD and elav. The conceptual translation product of rbp9 can be divided into five domains: the 106 amino acid N-terminal region, first RRM, second RRM, the 71 amino acids between the second and third RRM, and the third RRM. The amino acid sequence of rbp9 has a striking similarity to the proteins encoded by human HuC (Fumeaux, personal communication) , HUD (Szabo et al., 1991) , and Drosophila eluv (Robinow et al., 1988 ) genes (Fig. 8) . These three genes, like rbp9, encode proteins with three RRMs and are specifically expressed in the nervous system. The comparison of the sequences of these nerve-specific RRM proteins shows that they have a high degree of similarity: the three RRMs of rbp9 have 68%, 62%, and 69% identity to the corresponding RRMs of elav, whereas the rbp9 RRMs have 76%, 72%, and 69% identity to the corresponding RRMs of HUD. In addition, HuC and HUD showed 88% identity. The 70-90% identity shown here is outstanding considering that less than 20% identity is typically observed from the comparison of two random RRMs.
Even though the RRM sequences are highly conserved, two places, one each in the first and second RRM, show differences. In the first RRM, eluv has 13 extra amino acids near RNP-1, whereas RPB9-1 has 5 extra amino acids near the RNP-1 of the second RRM. Since the extra 5 amino acids in RBP9-1 originate from the alternative use of exon 9, the second RRM of RBP9-2 has even higher similarity to those of elav, HuC, and HUD (about 1% higher than RBP9-1). A tertiary structure analysis of an RRM showed that both of these places are within the loop-3 structure that lies next to RNP-1 consensus sequence in a P-sheet structure (Nagai et al., 1990; Hoffman et al., 1991) .
Essentially all the similarity between these proteins is restricted to their three RRMs; other regions of these proteins show only limited similarities. In N-terminal sequences, there is no obvious similarity between the proteins, but stretches of the Asn and Gln of rbp9, or the Ala and Gln of elav are noticeable, while HuC and HUD have a short N-terminal sequence without such sequences. The region between the second and third RRMs also shows no sequence conservation, and many gaps exist in the alignment. However, an octapeptide "R(F/ Y)SP(I/L)(A/T)XD" is conserved in all proteins. Besides this, stretches of Ala are also found in this region of elav and rbp9.
In situ hybridizations to larval salivary gland polytene chromosomes with an rbp9 cDNA probe showed that rbp9 gene is located in the cytological interval, 23C of the second chromosome. However, no genes with obvious nervous system-specific phenotypes are currently known in this region.
Discussion
There are three features of our findings that are striking. The first is that rbp9 encodes an RRM-type RNA binding protein. Second, rbp9 is expressed only in the adult nervous system. Third, a group of four nervous system-specific RRM genes, including rbp9, show high similarities to one another.
The fact that rbp9 has RRMs is very intriguing, since studies on a number of developmental processes have shown that RNA processing is a major mechanism for regulating the expression of developmentally important genes. Although more than 100 genes have been shown to be regulated at the level of RNA processing, only a few of the factors involved in regulating RNA processing choices have been isolated. However, ofthe few RNA processing regulators known, several have RRMs, and the presence of the RRM in a protein is very informative since many of the RRM proteins identified so far have a role in aspects of RNA metabolism. Moreover, in cases where the RNA binding activity of RRM proteins has been mapped, it has been shown that the RRM is necessary for RNA binding activity in each case, and in most, but not all, of these cases the RRM has also been shown to be sufficient for RNA binding (Sachs et al., 1987; Query et al., 1989; Scherly et al., 1989) . Therefore, the discovery of RRMs in rbp9 suggests that rbp9 may be directly involved in an RNA processing event.
Second, the tissue-and stage-specific expression pattern of rbp9 suggests that the RBP9 protein may be a regulatory factor involved in adult neurogenesis. RBP9 protein is localized to the nuclei of the CNS only after metamorphosis during the midpupal stage. During this metamorphosis, the neurons in the CNS change their physiology as well as their morphology drastically (Truman and Bate, 1988) . Therefore, the appearance of the RBP9 protein just after this morphological change indicates that the expression of rbp9 may be turned on in conjunction with differentiation of the adult nervous system and that rbp9 may be involved in an adult nervous system-specific function or in the maintenance of the differentiated nervous system.
The adult-and nervous system-specific expression of rbp9 indicates that the expression of rbp9 is highly regulated. The sequence analysis of the rbp9 cDNA and genomic DNA with the view to find putative regulation mechanisms revealed several putative promoter elements, and a complex gene structure including the three alternatively used promoters and alternative splicing of the small exon in the coding region. The alternatively used promoters do not affect the coding sequence. This suggests that the expression of rbp9 transcripts from each promoter may be regulated differently to achieve a very fine control of rbp9 expression. In addition, the existence of two RBP9 products resulting from the alternative splicing of exon 9 raises the possibility that the expression of the two RBP9 proteins is under the control of alternative splicing.
Lastly, the sequence of rbp9 has similarity to a group of RRM proteins, Drosophila elav and the human neural proteins HuC and HUD. These proteins also have nervous system-specific expression patterns. Drosophila elav is required for embryonic neurogenesis and the maintenance of the nervous system (Robinow and White, 1988) . The functions of the human genes HuC and HUD are not known, but a nervous system disorder observed in patients having an autoimmune serum that recognizes these proteins suggests that they have roles in nervous system-specific RNA processes (Grans et al., 1985) . Recently, P. King and J. D. Keene (personal communication) have isolated another rbp9 homolog from humans. These findings suggest that the gene family containing these nervous system-specific RRM genes may be sizable, and that the members of this gene family may participate in an important nervous system-specific process.
In our initial characterization of RRM sequences from Drosophila, we showed that a numerical analysis of sequence similarities clustered some of the RRMs we had cloned with the RRMs of previously identified proteins (e.g., rbp9 with elav) (Kim and Baker, in press ). We speculated that these sequence similarities might reflect functional similarities. The findings of similar tissue-specific patterns of expression of rbp9 and elav lends support to the speculation that they might encode similar functions. When taken together with similar findings of functional similarity between another of the RRMs that we cloned (rbpl; Kim et al., in press) and the gene with which it clustered (ASFSF2; Ge et al., 1991; Krainer et al., 1991) , these results suggest that the numerical analysis we used may be a useful tool for gaining insight into the functions of members of gene families.
Although the sequence comparison of rbp9 to elav, HuC, and HUD revealed more than 67% identities within the RRMs, it shows no significant similarities between the sequences outside RRMs of these proteins. The N-terminal sequences of these proteins have no detectable similarity to each other. While most of the region between the second and third RRMs has also diverged between these proteins, the presence of a conserved octapeptide sequence within this region suggests that the role of this region is more than just connecting these two RRMs. In addition, the differences within the RRMs of these proteins are very interesting considering the high degree of conservation of the RRM sequences between these proteins. In particular, the fact that both differences are at the loop-3 region, which lies at the N-terminal end of RNP-1 P-sheet, is intriguing. Since the loop-3 and RNP-1 sequences of U 1-A and U2-B" have been shown to determine the binding specificity of these proteins (Scherly et al., 1990; Bentley and Keene, 199 l) , the optional addition of 5 amino acids to the RBP9 protein in this region and the 13 extra amino acids of efav at the loop-3 region may confer on them different RNA binding specificities or affinities. In addition, the facts that two related fly proteins, elav and rbp9, have a different expression profile-eelav is required for the early embryo neurogenesis whereas rbp9 is expressed only at the late developmental stages-and that a rbp9 cDNA under the efav promoter failed to rescue the embryonic lethal phenotype of elav (K. M. Yao and K. White, personal communication) are consistent with the idea that these two proteins are involved in different functions rather than having synonymous functions in the CNS development.
The nervous system-specific expression patterns of members of this RRM gene family suggest that they may participate in some aspect of RNA processing during the nervous system de-System-Specific Expression of rbp9
velopment. However, we do not currently know for any of these four genes whether their putative RNA processing functions are at the level of alternative RNA splicing or some other aspect of RNA processing. The isolations of rbp9 mutants as well as the target RNA(s) to which the RBP9 protein may bind are obviously the next steps to understand the function(s) of rbp9.
